Nuclear Medicine Radiopharmaceuticals-Asia Pacific Market Status and Trend Report 2013-2023

January 2018 | 135 pages | ID: NF855C40C76EN
MIReports Co., Limited

Abstracts

Report Summary

Nuclear Medicine Radiopharmaceuticals-Asia Pacific Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Nuclear Medicine Radiopharmaceuticals industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

• Whole Asia Pacific and Regional Market Size of Nuclear Medicine Radiopharmaceuticals 2013-2017, and development forecast 2018-2023
• Main market players of Nuclear Medicine Radiopharmaceuticals in Asia Pacific, with company and product introduction, position in the Nuclear Medicine Radiopharmaceuticals market
• Market status and development trend of Nuclear Medicine Radiopharmaceuticals by types and applications
• Cost and profit status of Nuclear Medicine Radiopharmaceuticals, and marketing status
• Market growth drivers and challenges

The report segments the Asia Pacific Nuclear Medicine Radiopharmaceuticals market as:

Asia Pacific Nuclear Medicine Radiopharmaceuticals Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
China
Japan
Korea
India
Southeast Asia
Australia

Asia Pacific Nuclear Medicine Radiopharmaceuticals Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diagnostic
Brachytherapy
Other Therapeutic

Asia Pacific Nuclear Medicine Radiopharmaceuticals Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Oncology
Thyroid
Cardiology
Others

Asia Pacific Nuclear Medicine Radiopharmaceuticals Market: Players Segment Analysis (Company and Product introduction, Nuclear Medicine Radiopharmaceuticals Sales Volume, Revenue, Price and Gross Margin):
Mallinckrodt
Isorad
Cardinal Health
Jubilant
Medi-Radiopharma
Comecer
Jaco
Ciaeriar
Advanced Molecular-imaging Solution

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Contents

CHAPTER 1 OVERVIEW OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS

1.1 Definition of Nuclear Medicine Radiopharmaceuticals in This Report
1.2 Commercial Types of Nuclear Medicine Radiopharmaceuticals
  1.2.1 Diagnostic
  1.2.2 Brachytherapy
  1.2.3 Other Therapeutic
1.3 Downstream Application of Nuclear Medicine Radiopharmaceuticals
  1.3.1 Oncology
  1.3.2 Thyroid
  1.3.3 Cardiology
  1.3.4 Others
1.4 Development History of Nuclear Medicine Radiopharmaceuticals
1.5 Market Status and Trend of Nuclear Medicine Radiopharmaceuticals 2013-2023
  1.5.1 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023
  1.5.2 Regional Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023

CHAPTER 2 ASIA PACIFIC MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Nuclear Medicine Radiopharmaceuticals in Asia Pacific 2013-2017
2.2 Consumption Market of Nuclear Medicine Radiopharmaceuticals in Asia Pacific by Regions
  2.2.1 Consumption Volume of Nuclear Medicine Radiopharmaceuticals in Asia Pacific by Regions
  2.2.2 Revenue of Nuclear Medicine Radiopharmaceuticals in Asia Pacific by Regions
2.3 Market Analysis of Nuclear Medicine Radiopharmaceuticals in Asia Pacific by Regions
  2.3.1 Market Analysis of Nuclear Medicine Radiopharmaceuticals in China 2013-2017
  2.3.2 Market Analysis of Nuclear Medicine Radiopharmaceuticals in Japan 2013-2017
  2.3.3 Market Analysis of Nuclear Medicine Radiopharmaceuticals in Korea 2013-2017
  2.3.4 Market Analysis of Nuclear Medicine Radiopharmaceuticals in India 2013-2017
  2.3.5 Market Analysis of Nuclear Medicine Radiopharmaceuticals in Southeast Asia 2013-2017
  2.3.6 Market Analysis of Nuclear Medicine Radiopharmaceuticals in Australia 2013-2017
2.4 Market Development Forecast of Nuclear Medicine Radiopharmaceuticals in Asia Pacific 2018-2023
  2.4.1 Market Development Forecast of Nuclear Medicine Radiopharmaceuticals in Asia Pacific 2018-2023
  2.4.2 Market Development Forecast of Nuclear Medicine Radiopharmaceuticals by Regions 2018-2023

CHAPTER 3 ASIA PACIFIC MARKET STATUS AND FORECAST BY TYPES

3.1 Whole Asia Pacific Market Status by Types
  3.1.1 Consumption Volume of Nuclear Medicine Radiopharmaceuticals in Asia Pacific by Types
  3.1.2 Revenue of Nuclear Medicine Radiopharmaceuticals in Asia Pacific by Types
3.2 Asia Pacific Market Status by Types in Major Countries
  3.2.1 Market Status by Types in China
  3.2.2 Market Status by Types in Japan
  3.2.3 Market Status by Types in Korea
  3.2.4 Market Status by Types in India
  3.2.5 Market Status by Types in Southeast Asia
  3.2.6 Market Status by Types in Australia
3.3 Market Forecast of Nuclear Medicine Radiopharmaceuticals in Asia Pacific by Types

CHAPTER 4 ASIA PACIFIC MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Nuclear Medicine Radiopharmaceuticals in Asia Pacific by Downstream Industry
4.2 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in China
  4.2.2 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Japan
  4.2.3 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Korea
  4.2.4 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in India
  4.2.5 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Southeast Asia
  4.2.6 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Australia
4.3 Market Forecast of Nuclear Medicine Radiopharmaceuticals in Asia Pacific by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS

5.1 Asia Pacific Economy Situation and Trend Overview
5.2 Nuclear Medicine Radiopharmaceuticals Downstream Industry Situation and Trend Overview

CHAPTER 6 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN ASIA PACIFIC

6.1 Sales Volume of Nuclear Medicine Radiopharmaceuticals in Asia Pacific by Major Players
6.2 Revenue of Nuclear Medicine Radiopharmaceuticals in Asia Pacific by Major Players
6.3 Basic Information of Nuclear Medicine Radiopharmaceuticals by Major Players
  6.3.1 Headquarters Location and Established Time of Nuclear Medicine Radiopharmaceuticals Major Players
  6.3.2 Employees and Revenue Level of Nuclear Medicine Radiopharmaceuticals Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 NUCLEAR MEDICINE RADIOPHARMACEUTICALS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Mallinckrodt
  7.1.1 Company profile
  7.1.2 Representative Nuclear Medicine Radiopharmaceuticals Product
  7.1.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Mallinckrodt
7.2 Isorad
  7.2.1 Company profile
  7.2.2 Representative Nuclear Medicine Radiopharmaceuticals Product
  7.2.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Isorad
7.3 Cardinal Health
  7.3.1 Company profile
  7.3.2 Representative Nuclear Medicine Radiopharmaceuticals Product
  7.3.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Cardinal Health
7.4 Jubilant
  7.4.1 Company profile
  7.4.2 Representative Nuclear Medicine Radiopharmaceuticals Product
  7.4.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jubilant
7.5 Medi-Radiopharma
  7.5.1 Company profile
  7.5.2 Representative Nuclear Medicine Radiopharmaceuticals Product
  7.5.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Medi-Radiopharma
7.6 Comecer
  7.6.1 Company profile
  7.6.2 Representative Nuclear Medicine Radiopharmaceuticals Product
  7.6.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Comecer
7.7 Jaco
  7.7.1 Company profile
  7.7.2 Representative Nuclear Medicine Radiopharmaceuticals Product
  7.7.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jaco
7.8 Ciaeriar
  7.8.1 Company profile
  7.8.2 Representative Nuclear Medicine Radiopharmaceuticals Product
  7.8.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Ciaeriar
7.9 Advanced Molecular-imaging Solution
  7.9.1 Company profile
  7.9.2 Representative Nuclear Medicine Radiopharmaceuticals Product
  7.9.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Advanced Molecular-imaging Solution

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS

8.1 Industry Chain of Nuclear Medicine Radiopharmaceuticals
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS

9.1 Cost Structure Analysis of Nuclear Medicine Radiopharmaceuticals
9.2 Raw Materials Cost Analysis of Nuclear Medicine Radiopharmaceuticals
9.3 Labor Cost Analysis of Nuclear Medicine Radiopharmaceuticals
9.4 Manufacturing Expenses Analysis of Nuclear Medicine Radiopharmaceuticals

CHAPTER 10 MARKETING STATUS ANALYSIS OF NUCLEAR MEDICINE RADIOPHARMACEUTICALS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference